Inhibitors of elongation steps in protein synthesis such as cycloheximide and anisomycin mimic interferon treatment in that they specifically inhibit the synthesis of certain viral proteins. These specific effects are seen only at very low concentrations of the antibiotics, under conditions where host cellular protein synthesis, as well as cell viability, are not severely reduced. A qualitatively as well as quantitatively close correlation between the effects of the two types of agents has been established for encephalomyocarditis virus, vesicular stomatitis virus and murine leukemia virus protein synthesis. It is concluded that one of the primary mechanisms of interferon action may be a nonspecific retardation of one or more elongation steps,.and that this may be sufficient to account for its effects on the replication of certain viruses such as encephalomyocarditis and vesicular stomatitis viruses.
The mechanisms by which interferon-treated cells selectively repress virus replication are not well understood. Although many metabolic alterations have been described which are induced by interferon, it is not clear whether any of these are specific for viral, as opposed to host, functions. An additional difficulty arises from the fact that different viruses may be affected at different stages in their replicative cycles, and there is strong evidence for inhibition of viral transcription and translation, as well as maturation processes (3, 7, 23) .
In spite of these uncertainties it is clear that viral protein synthesis is a major, ifnot exclusive, target for interferon. Metz (23) has described a general theory to account for the specificity of interferon effects on viral versus host protein synthesis. He has assumed that most virulent viral mRNA's have high efficiencies for initiation, as we have found for encephalomyocarditis (EMC) virus (8, 10, 18) and as Koch and coworkers have proposed for reovirus (B. Baxt and G. Koch, personal communication), vesicular stomatitis virus (VSV) (25) , and poliovirus (26) . Metz has further proposed that few if any host mRNA's fall into this high-efficiency category. Thus, any agent which is more inhibitory for translation of high-than low-efficiency mRNA's will discriminate against viral protein synthesis. He points out that if interferon treatment produced such conditions in the cell cytoplasm, this would account for its selectivity in protein synthesis.
Metz was only able to speculate as to what biochemical features might distinguish highfrom low-efficiency mRNA's, and therefore he was unable to describe in detail the nature of the proposed changes induced by interferon. Some recent experiments on EMC viral protein synthesis shed light on this problem. First, it has been found that EMC RNA is a more effective initiator than host mRNA in vitro (8, 18) and that this is probably due to its preferential interaction with messenger discriminatory initiation factors. Second, it has recently been shown that EMC RNA initiates at a much higher rate than host mRNA in vivo, to the extent that the elongation rate on viral mRNA is limiting; in contrast, the rate of initiation is the slow step in host mRNA translation (10) . These two observations taken together suggest that the interaction of mRNA with initiation factors may ordinarily be the rate-determining step for protein synthesis in the uninfected cell. It also appears likely that viruses have evolved mechanisms for speeding up the initiation reaction, possibly by increasing their affinity for initiation factors.
This would bestow on them the dual advantages of (i) being able to assure that a single entering virus mRNA would be rapidly translated, and (ii) being able to outcompete host mRNA's, which ordinarily would be present in excess, for initiation factors late in the course of infection.
These observations lead to testable hypotheses as to how interferon might work. Thus, in general terms, if interferon treatment were to slow some non-discriminatory step in protein synthesis which occurs subsequent to the putative messenger discriminatory step to the point that the former becomes rate limiting for all translation, then the selective advantage of viral mRNA's would be lost and they would be translated at the same relative rates as host mRNA's.
How can this hypothesis be tested? One obvious way is simply to use inhibitors of elongation in low doses so as to create a new rate-limiting step subsequent to initiation (10) . If the above hypothesis is correct, then this should eliminate the advantage in translation that viral mRNA's usually enjoy and thereby reduce virus protein synthesis, and hence virus yield, without seriously affecting host protein synthesis. It has already been shown that EMC RNA translation is greatly reduced relative to host translation by treatment with elongation inhibitors (10). The critical experiment, then, is to see if the production of EMC virus is severely inhibited by a dose of elongation inhibitor low enough to not substantially affect host functions. (Only if this condition is met does the comparison between antibiotics and interferon have any significance, since inhibition of viral functions by high drug concentrations is to be expected and is a trivial result.) The results described in the present communication show that this is true, and that elongation inhibitors and interferon have similar effects on rates of cellular protein synthesis and overall cell growth rate, as well as on virus production. These results have also been extended and generalized in similar studies with VSV and murine leukemia virus (MuLV). The major conclusion to be drawn from this work is that interferon may well exert its messenger discriminatory effects in protein synthesis by slowing nonspecifically one or more elongation steps. Moreover, for some viruses, such as EMC and VSV, this effect could well be the primary means by which interferon inhibits viral replication. Growth and assay of viruses. EMC virus was grown in Krebs ascites cells as previously described (18) . It was further purified by sucrose gradient sedimentation and banded on a cesium chloride gradient as described by Kerr and Martin (14) . Cesium chloride gradient-purified virus was then dialyzed overnight against phosphate-buffered saline (PBS) at 4°C and diluted with PBS to a concentration of 1012 PFU/ml. VSV was obtained from S. Schlesinger of Washington University and grown in L cells.
MATERIALS AND METHODS
Virus titer was determined by the hemagglutination assay (18) or by plaque assay on mouse L cells (22) .
Production and assay of interferon. L cells for interferon production were grown in a T flask with a 75-cm2 growth area until they reached confluency. DEAE-dextran, purchased from Sigma Chemical Co., St. Louis, Mo., was added to a final concentration of 50 Ag/ml; a complex of polyinosinic and polycytidylic acid, purchased from Microbiological Associates, Walkerville, Md., was added to a final concentration of 5 ,tg/ml. After 90 min of incubation at 37°C, growth medium with DEAE-dextran and polyinosinic acid:polycytidylic acid complex was removed by aspiration, cells were washed thoroughly with PBS three times, fresh growth medium was added, and cultures were further incubated for 20 h at 37°C. Crude interferon was obtained after centrifugation at 10,000 x g for 10 min. The clarified supernatant was stored at -700C.
Interferon was assayed by a microassay technique on L cells as described by Knight (15) After trichloroacetic acid precipitation at a final concentration of 5%, the proteins were washed twice with acetone, redissolved in sample buffer, and analyzed by polyacrylamide gel electrophoresis (PAGE) in sodium dodecyl sulfate (SDS) as previously described (18) . Two gel systems were used: linear 7.5 to 20% polyacrylamide gradient gels for EMC virus and reovirus pro-teins, and 12 Visualization and quantitation ofradioactivity on polyacrylamide gels. Gels containing a sufficient amount of 35S were dried and exposed to Kodak XR-5 film. Otherwise they were treated for fluorography and exposed to preflashed XR-5 film at -70°C (17) . RESULTS Inhibitors of elongation steps in protein synthesis such as cycloheximide and anisomycin are ordinarily not thought to be messenger specific in their effects. Nevertheless, when used at very low concentrations, these agents can be highly selective in inhibiting virus as opposed to host translation. This effect is demonstrated in Fig.  1 , where cycloheximide at a concentration of 0.1 ,uM virtually eliminates the synthesis of virus proteins while leaving the pattern of host protein synthesis relatively unaffected. We have argued elsewhere that this is due to the fact that elongation is rate limiting for EMC RNA translation, whereas initiation is rate limiting for host translation (10) . In particular, it should be noted that the selective effects produced when cycloheximide is added to cells simultaneous with virus (as in Fig. 1 ) are also obtained when it is added at 4.5 h postinfection, shortly before the [35S]methionine pulse (10) . This result shows that the selective effects of cycloheximide are due to an instantaneous slowing of elongation steps per se and not to inhibition of some other, unrelated early event in virus infection.
Results similar to those shown in Fig. 1 have also been obtained with another elongation step inhibitor, anisomycin (11) . At a concentration of 0.13 LM, viral protein synthesis is undetectable above the cellular protein synthesis background (data not shown). In contrast, inhibitors of initiation steps such as pactamycin (Fig. 2) , herringtonine, and hypertonic initiation block do not produce this result. Indeed, with the latter the discrimination is reversed, viral translation being more resistant than host, as originally reported by Nuss et al. (26) for poliovirus (data not shown). Results similar to those in Fig. 1 were also obtained using MOPC-460TC cells in place of L cells.
The selective inhibition of viral protein synthesis shown in Fig. 1 suggests that the overall production of EMC virus should be inhibitable by very low concentrations of cycloheximide.
That this is indeed true is shown in Fig. 3A .
Here it is evident that an antibiotic concentration (0.3 ,M) which only results in a 20% inhibition of the overall rate of protein synthesis in infected cells inhibits virus production by over 97%. It is interesting to compare the degree of specificity obtained by cycloheximide to that produced by interferon treatment. The results presented in Fig. 3B show that interferon produces effects which in many respects are similar to those obtained with cycloheximide. Of particular significance is the fact that interferon produces a slight but reproducible inhibition of the overall rate of protein synthesis in EMC-infected cells. Thus, at a dose of interferon (10 U/ml) that gives a 94% inhibition of virus yield, the overall rate of protein synthesis is inhibited by 13%. These numbers are similar to those mentioned above for cycloheximide. However, it is important to note that the analogy between interferon and cycloheximide is by no means perfect, and that wide discrepancies occur when higher concentrations of the two are compared: increasing concentrations of cycloheximide ultimately block all protein synthesis, whereas a plateau is reached with interferon beyond which further addition of this substance produces no further inhibitory effect.
The experiments shown in Fig. 3 bition seen with interferon might be due to impurities).
The analogy between elongation inhibitors and interferon also holds true for viruses other than EMC. This is demonstrated in Fig. 5 and 6 , where the effects of cycloheximide on VSV protein synthesis and virion production are shown. It is evident that VSV translation is selectively inhibited relative to host translation by low concentrations of cycloheximide (Fig. 5) , in a manner similar to that observed for EMC translation (Fig. 1) . However, in contrast to the situation with EMC-infected cells, both cycloheximide and interferon appear to stimulate the overall rate of protein synthesis in VSV-infected cells (Fig. 6) reported that interferon treatment has little or no effect on viral protein synthesis (7, 28, 35) . Thus, if elongation inhibitors and interferon are acting on protein synthesis by similar mechanisms, we would expect to find that MuLV translation is not selectively inhibited by the former. That this is indeed the case is shown in Fig. 7A , where it is evident that the synthesis of the MuLV protein p30 is inhibited by cycloheximide to exactly the same extent as total cellular translation. Figure 7B serves as a control experiment, showing that in our system interferon treatment does not selectively block p30 synthesis, although the release of virus into the medium (as indicated by the amount of labeled p30 that can be chased into the medium) is considerably reduced, as reported by others (1, 7, 28, 35 ). It should be noted, however, that the similarity of interferon and cycloheximide effects on p30 synthesis cannot be extended to their effects on MuLV production. In fact, cycloheximide only inhibits virus production to the extent that it inhibits viral protein synthesis. (When cells were exposed to varying levels of cycloheximide for prolonged periods of time, i.e., several days, viral production was inhibited to the same extent as protein synthesis, in direct proportion to antibiotic concentration [data not shown].) In contrast, very low levels of interferon (10 U/ml) block virus release without affecting p30 synthesis appreciably (Fig. 7B) . Thus, even though the analogy between interferon and elongation inhibitors cannot account for all the effects of interferon on MuLV metabolism, the above data strongly suggest that their resemblance is more than superficial, and that they may indeed act on protein synthesis by similar mechanisms.
Further evidence for this comes from a study of the effects of cycloheximide on reovirus protein synthesis (T. Brendler, C. Birge, P. Yau, and R. Thach, unpublished observations). Wiebe and Joklik (34) synthesis of the various reovirus proteins is inhibited to different degrees by interferon treatment. Some, such as a3, are relatively resistant to interferon, whereas others are more sensitive, the most strongly inhibited being A1. Again, if cycloheximide and interferon are acting via similar mechanisms, then treatment of reovirus-infected cells with cycloheximide should produce a quantitatively sirnilar differential effect. Preliminary experiments have confirmed this prediction and will be described in detail elsewhere.
DISCUSSION
The experiments described above show that inhibitors of elongation steps in protein synthesis mimic interferon in their effects on viral as opposed to host protein synthesis for the three viruses tested, EMC virus, VSV, and MuLV. Moreover, the two types of agents showed similar effects on the lysis of virus-infected cells. Whereas most of the data were obtained using cycloheximide, similar results in several experiments with EMC were seen with anisomycin (see also reference 10). Inasmuch as these antibiotics act via quite different molecular mechanisms (9) , it seems likely that other inhibitors of elongation will have comparable effects. (The action of the pokeweed antiviral agent, which has been shown by Obrig et al. [27] to be an inhibitor of elongation, supports this view.)
It should be noted that all of the comparative studies reported here were made using crude interferon. Recently we have repeated many of the key observations by using a 50-fold-purified preparation: qualitatively and quantitatively similar results were obtained in all cases, except that the more purified preparations showed less inhibition of cell growth rate (cf. Fig. 4) .
The mechanism by which elongation inhibitors and interferon act on protein synthesis are likely to be similar, since translation of mRNA's which are resistant to the latter are also relatively resistant to the former (as shown by the studies on MuLV protein synthesis). This conclusion is consistent with previous reports of an inhibitory effect ofinterferon on elongation steps in protein synthesis (5, 6, 13, 30) . However, the precise mechanism by which elongation is slowed by interferon is not clear. A major obstacle to drawing too close an analogy between interferon action and the effects of elongation inhibitors is that whereas the latter tend to increase the size of host polysomes and leave unchanged the size of viral polysomes (10) , the former clearly leads to a specific reduction in viral polysome size (36) . This discrepancy is difficult to explain at present and suggests that important differences between the modes of action of the two types of agents do exist. One VOL. 27, 1978 mechanism which would be consistent with all the data is that interferon might reduce the rate of only one or a few steps, which are randomly distributed along the full length of the mRNA. These sensitive sites would affect a rapidly initiating message by reducing the number of ribosomes on the mRNA (i.e., polysome size). The extent of this reduction would be in proportion to the fraction of the message which lies to the 3' side of the sensitive site proximal to the 3' end. (There would be no change in the ribosome density along that portion of the mRNA which lies to the 5' side of this sensitive site, since ribosomes should be maximally close packed in this region in any case [10] .) In contrast, the average number of ribosomes on a slowly initiating mRNA might decrease or increase, depending upon the locations of the sensitive sites. (A reduction in ribosome density toward the 3' end of the mRNA might be counterbalanced by an increase toward the 5' end, where the normally low ribosome density would be enhanced by the "queuing up" of ribosomes proxiimal to the first sensitive site encountered.) Indeed, the introduction of a few sensitive sites at random might have little or no discernible effect on the aggregate size distribution of slowly initiating host mRNA's. A possible mechanism for the creation of such sensitive sites might be the selective inactivation of a few tRNA molecules in the interferon-treated cells. There is evidence both for and against such interferon-induced tRNA inactivation occurring in vivo (4, 5, 31, 37) . Thus, this hypothesis must be viewed as speculative at present. In any event, our results suggest that some step(s) which occurs subsequent to the messenger discriminatory step in initiation is the primary target of interferon for certain viruses, such as EMC and VSV, since its effects are mimicked so closely by the antibiotics.
It is of interest to note that interferon has been reported to inhibit not only an elongation step(s) in protein synthesis, but an initiation step(s) as well (5, 12, 23, 30) . However, the latter type of inhibition is predominant only in extracts prepared from interferon-treated, virus-infected cells (12, 23) ; in contrast, in the absence of virus infection the primary target of interferon seems to be the elongation step (5, 30 (13) , this would limit the spread of the virus infection in an intact animal. It would thus serve as a "backup" system to the first-phase effects. The rationale for why general inhibitors of elongation steps should specifically inhibit the translation of certain viral mRNA's more than that of host mRNA's has been described above.
In agreement with the prediction of Metz (23) and the results of others (10, 25, 26) , our findings suggest that any viral mRNA whose translation is sensitive to interferon will be found to initiate unusually rapidly in its normal host cell. It must be emphasized that certain elements of this rationale are still hypothetical, however, and remain to be proven experimentally. Suffice it to add here that our results are entirely consistent with the work of others on protein synthesis kinetics (19, 20) .
Finally, it should be pointed out that the antiviral effects shown by elongation inhibitors may prove useful in the treatment of certain viral diseases in higher organisms, including humans. The very low concentrations required for antiviral action in tissue culture suggests that the ordinarily toxic side effects of these antibiotics may be minimized in whole organisms.
